BENZENE COMPOUND, AND USE THEREOF FOR MEDICAL PURPOSES

Disclosed is a novel benzene compound which has an excellent immunosuppressing activity, an excellent rejection-inhibiting effect and others, and is reduced in adverse side effects including bradycardia. Specifically disclosed is a compound represented by general formula (I), (II-1), (II-2), (III-1)...

Full description

Saved in:
Bibliographic Details
Main Authors SUGAHARA, KUNIO, SAKASHITA, HIROSHI, HAMADA, MAIKO, KIUCHI, MASATOSHI, TASHIRO, KAORU
Format Patent
LanguageEnglish
French
Japanese
Published 01.10.2009
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed is a novel benzene compound which has an excellent immunosuppressing activity, an excellent rejection-inhibiting effect and others, and is reduced in adverse side effects including bradycardia. Specifically disclosed is a compound represented by general formula (I), (II-1), (II-2), (III-1), (III-2), (IV-1), (IV-2) or (V). Cette invention concerne un nouveau composé benzénique qui a une excellente activité immunodépressive, un excellent effet inhibiteur de rejet et autres, et a des effets secondaires défavorables réduits comprenant la bradycardie. Un composé représenté par la formule générale (I), (II-1), (II-2), (III-1), (III-2), (IV-1), (IV-2) ou (V) est spécifiquement décrit.
Bibliography:Application Number: WO2009JP56400